Algae Dynamics Corp. (OTCQB: ADYNF) sees opportunity and greater market share in a soon to be legalized marijuana industry in Canada.
Cannabis News
California Wildfires Torch Cannabis Farms at Height of Harvest Season
Just months before California is poised to legalize recreational marijuana, fatal wildfires tearing through three northern counties have scorched an untold number of cannabis farms.
Cannabis gets in on Pumpkin Spice Season
GOOD CO-OP releases Pumpkin Spice Blondie exclusively on Eaze.
Mounting Evidence on Therapeutic Benefits of Cannabis Unleashes Tsunami
Cannabidiol (CBD), a non-psychoactive compound found in the cannabis sativa plant, has shown tremendous promise for broad-ranging medical benefits, and consumers are taking notice.
5 CANNABIS BIOTECH STOCKS TO WATCH
These 5 Biotechs including InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) have a combined market cap of over $4 Billion. What should investors know about future growth for these companies?
Emblem Announces $25 Million Bought Deal
Emblem Corp. (TSX VENTURE:EMC)(TSX VENTURE:EMC.WT) announces that it has entered into a letter of engagement with Eight Capital under which Eight Capital has agreed to purchase 5,714,300 units (the "Units") and 15,000 convertible unsecured debentures of the Company
Skinvisible, Inc. (SKVI) Has Been Delivering its Patented Polymer Technology to Pharmaceuticals & Cosmeceuticals for Close to Two Decades
Invisicare is a patented polymer delivery system that improves the delivery of topically applied skin care products, thereby enhancing the efficacy of the active ingredients.
ABcann Global Puts The 'Green' In Green Rush
Seekingalpha.com recently posted an in-depth article looking at ABcann Global (TSX.V: ABCN OTCQB: ABCCF) and how well positioned it is in this emerging market. It's a great read for those interested in this company that we've identified as one of Canada's Strongest Growers.
InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) Biosynthesis Technology Demonstrates Robust Diversity
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids
ChineseInvestors.com, Inc. (CIIX) Poised to be First to Market in China’s Multibillion-Dollar Skin Care Industry with Line of Cannabidiol-Based Products
ChineseInvestors.com (OTCQB: CIIX) is quickly moving into the multibillion-dollar Chinese skin care industry and is introducing its first line of cannabidiol (CBD) based skin care products.
Corporate Canada warms to marijuana industry
With expectations of the Canadian Marijuana Industry exploding, well-known figures from corporate Canada are moving into prominent positions within the industry.
MCIG Enters into the Cryptocurrency Market, Partnering with Render Payment
mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets, enters into the cryptocurrency market, partnering with Render Payment during its Pre-ICO (Initial Coin Offering).
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF) Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), announces the addition of Dr. Mauro Maccarrone to its Scientific Advisory Board. Dr. Maccarrone has vast experience in the field of cannabinoid research.
Maricann Group Inc. Partners with International Cannabrands Ltd., and Julian Marley to bring JuJu Royal™ Products to Canada and Western Europe
Maricann Group Inc., has partnered with Julian Marley and International Cannabrands Ltd. to cultivate and formulate JuJu Royal™, a premium and market established group of products.
The Green Organic Dutchman Holdings Ltd. Increases Financing to $30,000,000 Due to Demand
The Green Organic Dutchman Holdings Ltd. announced it will increase its previously announced brokered unit offering and non-brokered offering of 12,121,500 Units of the Company for aggregate gross cash proceeds of C$20,000,475. The Company will issue an additional 6,060,700 Units of the Company at $1.65 for aggregate gross cash proceeds of C$30,000,630.